Literature DB >> 29334428

Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages.

Marco Paolino1, Margherita Brindisi1, Alessandra Vallone1, Stefania Butini1, Giuseppe Campiani1, Chiara Nannicini1, Germano Giuliani1, Maurizio Anzini1, Stefania Lamponi1, Gianluca Giorgi1, Diego Sbardella2, Davide M Ferraris3, Stefano Marini2, Massimo Coletta2, Ivana Palucci4, Mariachiara Minerva4, Giovanni Delogu4, Ilaria Pepponi5, Delia Goletti5, Andrea Cappelli1, Sandra Gemma1, Simone Brogi1.   

Abstract

The enzyme Zmp1 is a zinc-containing peptidase that plays a critical role in the pathogenicity of Mycobacterium tuberculosis. Herein we describe the identification of a small set of Zmp1 inhibitors based on a novel 8-hydroxyquinoline-2-hydroxamate scaffold. Among the synthesized compounds, N-(benzyloxy)-8-hydroxyquinoline-2-carboxamide (1 c) was found to be the most potent Zmp1 inhibitor known to date, and its binding mode was analyzed both by kinetics studies and molecular modeling, identifying critical interactions of 1 c with the zinc ion and residues in the active site. The effect of 1 c on intracellular Mycobacterium survival was assayed in J774 murine macrophages infected with M. tuberculosis H37Rv or M. bovis BCG and human monocyte-derived macrophages infected with M. tuberculosis H37Rv. Cytotoxicity and genotoxicity were also assessed. Overall, inhibitor 1 c displays interesting in vitro antitubercular properties worthy of further investigation.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  8-hydroxyquinoline-2-hydroxamate; Mycobacterium tuberculosis; QPLD; Zmp1; metalloprotease inhibitors

Mesh:

Substances:

Year:  2018        PMID: 29334428     DOI: 10.1002/cmdc.201700759

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  12 in total

Review 1.  Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis.

Authors:  Vadim Makarov; Elena Salina; Robert C Reynolds; Phyo Phyo Kyaw Zin; Sean Ekins
Journal:  J Med Chem       Date:  2020-04-20       Impact factor: 7.446

2.  Structural analysis of Mycobacterium tuberculosis M13 metalloprotease Zmp1 open states.

Authors:  Wenguang G Liang; Jordan M Mancl; Minglei Zhao; Wei-Jen Tang
Journal:  Structure       Date:  2020-12-29       Impact factor: 5.006

3.  Large-Scale Analysis of the Mycoplasma bovis Genome Identified Non-essential, Adhesion- and Virulence-Related Genes.

Authors:  Christoph Josi; Sibylle Bürki; Sara Vidal; Emilie Dordet-Frisoni; Christine Citti; Laurent Falquet; Paola Pilo
Journal:  Front Microbiol       Date:  2019-09-13       Impact factor: 5.640

4.  Genetic and Virulence Characteristics of Linezolid and Pretomanid Dual Drug-Resistant Strains Induced from Mycobacterium tuberculosis in vitro.

Authors:  Minghao Hu; Lei Fu; Bin Wang; Jian Xu; Shaochen Guo; Jiaojie Zhao; Yuanyuan Li; Xiaoyou Chen; Yu Lu
Journal:  Infect Drug Resist       Date:  2020-06-12       Impact factor: 4.003

5.  Vaccines Against Tuberculosis: Problems and Prospects (Review).

Authors:  N I Nadolinskaia; D S Karpov; A V Goncharenko
Journal:  Appl Biochem Microbiol       Date:  2020-09-22       Impact factor: 1.065

6.  Discovery of uncompetitive inhibitors of SapM that compromise intracellular survival of Mycobacterium tuberculosis.

Authors:  Paulina Fernández-Soto; Joshua Casulli; Danilo Solano-Castro; Pablo Rodríguez-Fernández; Thomas A Jowitt; Mark A Travis; Jennifer S Cavet; Lydia Tabernero
Journal:  Sci Rep       Date:  2021-04-07       Impact factor: 4.379

7.  Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors.

Authors:  Giuseppe Campiani; Caterina Cavella; Jeremy D Osko; Margherita Brindisi; Nicola Relitti; Simone Brogi; A Prasanth Saraswati; Stefano Federico; Giulia Chemi; Samuele Maramai; Gabriele Carullo; Benedikt Jaeger; Alfonso Carleo; Rosaria Benedetti; Federica Sarno; Stefania Lamponi; Paola Rottoli; Elena Bargagli; Carlo Bertucci; Daniele Tedesco; Daniel Herp; Johanna Senger; Giovina Ruberti; Fulvio Saccoccia; Simona Saponara; Beatrice Gorelli; Massimo Valoti; Breándan Kennedy; Husvinee Sundaramurthi; Stefania Butini; Manfred Jung; Katy M Roach; Lucia Altucci; Peter Bradding; David W Christianson; Sandra Gemma; Antje Prasse
Journal:  J Med Chem       Date:  2021-07-12       Impact factor: 8.039

Review 8.  Mycobacterium tuberculosis Molecular Determinants of Infection, Survival Strategies, and Vulnerable Targets.

Authors:  Davide M Ferraris; Riccardo Miggiano; Franca Rossi; Menico Rizzi
Journal:  Pathogens       Date:  2018-02-01

9.  A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting Profiles.

Authors:  Basem Battah; Giulia Chemi; Stefania Butini; Giuseppe Campiani; Simone Brogi; Giovanni Delogu; Sandra Gemma
Journal:  Molecules       Date:  2019-11-29       Impact factor: 4.411

10.  Cinnamides Target Leishmania amazonensis Arginase Selectively.

Authors:  Edson Roberto da Silva; Júlio Abel Alfredo Dos Santos Simone Come; Simone Brogi; Vincenzo Calderone; Giulia Chemi; Giuseppe Campiani; Trícia Maria Ferrreira de Sousa Oliveira; Thanh-Nhat Pham; Marc Pudlo; Corine Girard; Claudia do Carmo Maquiaveli
Journal:  Molecules       Date:  2020-11-12       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.